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Abstract

NIH-PA Author Manuscript

The pH (low) insertion peptide (pHLIP) has exceptional characteristics: at neutral pH it is an
unstructured monomer in solution or when bound to lipid bilayer surfaces, and it inserts across a lipid
bilayer as a monomeric alpha-helix at acidic pH. The peptide targets acidic tissues in vivo, and may
be useful in cancer biology for delivery of imaging or therapeutic molecules to acidic tumors. To
find ways to vary its useful properties, we have designed and analyzed pHLIP sequence variants. We
find that each of the Asp residues in the transmembrane segment is critical for solubility and pHdependent membrane insertion of the peptide. Changing both of the Asp residues in the
transmembrane segment to Glu, inserting an additional Asp into the transmembrane segment, or
replacing either of the Asp residues with Ala leads to aggregation and/or loss of pH-dependent
membrane insertion of the peptide. However, variants with either of the Asp residues changed to Glu
remained soluble in an aqueous environment and inserted into the membrane at acidic pH with a
higher pKapp of membrane insertion. Variation of the pH at which insertion occurs may broaden the
potential uses of the pHLIP technology by allowing targeting of tissues with different acidity levels.
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Analysis of a 36-residue polypeptide containing the sequence of the bacteriorhodopsin C-helix
revealed a peptide with exceptional properties (1). The peptide is soluble in aqueous solution
and associates with lipid bilayers as an unstructured monomer at neutral pH, and inserts across
a bilayer or membrane as an alpha-helix at acidic pH. Thus the peptide has been named pH
(low) insertion peptide (pHLIP) (2). pHLIP's exceptional properties are being applied in cancer
biology, where acidosis is a known feature of solid tumors. Tissue acidity is also found in other
pathological conditions, such as inflammation sites and focal lesions caused by infection,
ischemia and stroke. pHLIP insertion into cell membranes at low pH (pH below neutral) has
been shown to localize tumors and inflammation sites in mice and rats (3,4). The variations of
acidity in different tumors or different diseased tissues are not well understood, but it is likely
that significant differences exist, and variations among tumors are suggested by some studies
(REFERECES HERE). Thus, an ability to tune the pH of insertion of pHLIP could be an
advantage in differentially imaging and treating tissues of differing acidity.
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In addition to selective targeting of acidic solid tumors in vivo pHLIP has been used to
translocate cargo molecules into the cytoplasms of cultured cancer cells (4). This phenomenon
may allow the use of the peptide to deliver relatively polar therapeutic molecules to cells in
acidic tissues. Further, the peptide might be exploited to study the process of spontaneous
peptide folding and insertion into lipid bilayers. Amphipathic peptides have been used to
understand the kinetics, thermodynamics or structures of membrane proteins (5-10). It is well
established that the folding of a single helix can initiate the assembly of more complex
membrane proteins (8,11-17), so the study of pHLIP insertion can extend such understanding,
particularly since it remains a monomer in all stages.
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It is known that pHLIP peptide is monomeric at concentrations up to 7 μM both in aqueous
solution and in lipid bilayers (2). In the formation of a transmembrane helix at low pH, the
polar C-terminus is reversibly inserted into the cytoplasm while the N-terminus remains on the
outside (2). Most recently it has been shown that the peptide binding interaction with the lipid
surface is strong, and it has been proposed that the peptide associates with the surfaces of
membranes in vivo, such as the blood cell membranes, until it finds itself in an acidic
environment and only then inserts across the membranes of cells in that environment(18). It is
also important to note that membrane integrity is preserved at all stages of peptide interaction
(19). The peptide loses its pH dependent insertion properties when the two Asp residues from
the transmembrane segment are replaced with either two Asn or Lys residues (4). This finding
points to the involvement of these two Asp residues, or at least one of them, in the pH dependent
membrane insertion. Further, changes in the peptide by neutralizing the C-terminus lead to
helix formation in solution and loss of insertion properties (19). We are working to further
understand the roles of different sequence features in solubility and insertion, and in this study
we report further evidence for the role of the two Asp residues, and the discovery that the pK
of insertion can be varied while preserving useful properties of the peptide. Such variation
informs us further about membrane insertion and may broaden the applicability or specificity
of the pHLIP technology in the clinic.

METHODS
Peptide preparation

NIH-PA Author Manuscript

Variants of pHLIP were made by solid-phase peptide synthesis using standard 9fluorenylmethyloxycarbonyl chemistry and purified by reverse phase chromatography (on a
C18 column) at the W.M. Keck Foundation Biotechnology Resource at Yale University (New
Haven, CT). The lyophilized peptide was dissolved in a solution containing 6 M urea and
dialyzed against 5 changes of 1 L of phosphate buffer (50 mM Na2HPO4, 10 mM NaCl, pH
8) each. The concentration of the peptide was determined by absorbance using ε280 = 13, 940
M−1 cm−1.
Liposome preparation
Large unilamellar vesicles were prepared by extrusion (20). POPC (1-Palmitoyl-2-Oleoyl-snGlycero-3-Phosphocholine) (Avanti Polar Lipids, Inc., Alabaster, AL) lipids in chloroform
were de-solvated with N2 and dried under vacuum at room temperature overnight. The
phospholipid film was rehydrated in 50 mM Na2HPO4, 10 mM NaCl, pH 8, freeze-thawed 7
times, and passed through the extruder (200 nm membrane) 15 times.
Tryptophan fluorescence and CD measurements
Tryptophan fluorescence and CD measurements were carried out on an ISS spectrofluorometer
and a Jasco 810 spectropolarimeter, respectively, under regulated temperature control.
Tryptophan fluorescence spectra were recorded from 310 nm to 450 nm at an excitation
wavelength of 295 nm, with the spectral width of the excitation and emission slits set at 2-4
Biochim Biophys Acta. Author manuscript; available in PMC 2010 June 1.
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nm and 2 nm, respectively. Trp fluorescence and CD spectra of the peptides at 7 μM, unless
otherwise mentioned, were measured in phosphate buffer of different pHs in the absence or
presence of POPC liposomes. To avoid aggregation of the peptide at low pH, the lipid vesicles
were added first and the peptide was added last, although we have found that some versions
of the peptide can still insert when lipid vesicles are added to aggregated peptide in a buffer at
pH 4 (data not shown). The pH was adjusted by addition of microdrops of diluted NaOH or
HCl.

RESULTS AND DISCUSSION
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The objective of our study was to use sequence variation of pHLIP to better document key
properties of the peptide, and to identify peptides with useful membrane targeting variations.
We demonstrated earlier that the simultaneous replacement of two key Asp residues located
in the transmembrane part of pHLIP by Lys or Asn led to the loss of pH-sensitive insertion
into membranes of liposomes, red blood cells, and cancer cells, as well as to the loss of specific
accumulation in tumors in vivo (4). Individual variations of the Asps were not investigated,
nor were more conservative substitutions. To further clarify the role of the two individual Asp
residues, we replaced each of them with Ala (the D14A and D25A variants). Additionally, we
studied the possibility of tuning the pKa of pHLIP insertion across a membrane, and/or
enhancing the cooperativity of the transition. Thus, several pHLIP variants were designed and
their interactions with lipid bilayer of POPC vesicles were studied by fluorescence and CD
spectroscopy.
Design of pHLIP variants

NIH-PA Author Manuscript

We guided the design of pHLIP sequence variations using the apparent free energy difference
(ΔGapp) for membrane insertion. The calculations were performed using the algorithm
developed by Gunnar von Heijne and colleagues
(http://www.cbr.su.se/DGpred/index.php?p=TMpred), which is based on the experimental
analysis of TM helix insertion into a membrane by the Sec61 translocon (21,22). A negative
value of ΔGapp indicates that the sequence would be likely to adopt a stable transmembrane
helix (TM) configuration. The apparent free energy difference depends on the hydrophobic
moment (ΔGhyd mom), the length of the helix (ΔGlength) and the position of polar amino acids
within the transmembrane segment (ΔGaaapp). Using this tool we designed the peptides
sequences presented in table 1, with the corresponding predicted ΔGapp values shown in table
2. All predicted values of the apparent free energy difference are calculated based on the
assumption of neutral pH, where Asp residues carry negative charges, therefore, transferring
them into the hydrophobic core of a membrane accounts for the large energetic penalty and
calculations provide positive values of ΔGapp. As expected, our experimental data suggest that
pHLIP does not insert across a membrane at neutral pH, while decreasing the pH leads to
protonation of the Asp residues and increase peptide hydrophobicity, shifting the equilibrium
toward the inserted TM configuration of the peptide. Our overall goal in designing new
sequences was to preserve the major properties of WT-pHLIP, particularly monomeric
solubility in aqueous solution and an ability to insert across a membrane in a pH-dependent
manner. Therefore, we selected variants with similar values of ΔGapp to that of WT-pHLIP.
Three states of WT-pHLIP
The fluorescence emission of tryptophan residues and circular dichroism signals of WT-pHLIP
are distinct in each of the three states (Fig. 1) and were used to follow membrane surface
adsorption and insertion of the peptide (and its variants) across a bilayer (Figure 1) (23). WTpHLIP in solution at low concentrations is unfolded and monomeric, and the tryptophan
residues are exposed to the polar environment, resulting in an emission spectrum with a
maximum around 349 nm (Table 3), which is characteristic for class III tryptophan residues
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fully exposed to water (24). In the presence of POPC vesicles, the tryptophan fluorescence of
WT-pHLIP is blue shifted and the intensity is increased, while the peptide remains unstructured
as observed from the CD spectrum. When the pH is decreased to 4, tryptophan fluorescence
shifts further (since tryptophan residues are moved into the hydrophobic core of the bilayer),
the intensity increases (due to lower water quenching of tryptophan emission), and the peptide
becomes alpha helical. All changes of fluorescence and CD point to the peptide being
associated in an unstructured fashion with the lipid surface at pH 8 and inserted into the lipid
bilayer as an alpha helix at pH 4, and the transmembrane orientation of WT-pHLIP was
established earlier by FTIR analysis (14).
Ala-pHLIP variants

NIH-PA Author Manuscript

Titration of the two Asp carboxyl groups to make them more hydrophobic is our working model
for the trigger of insertion and TM formation. To further test the role of each Asp residue in
the mechanism of pHLIP insertion at low pH, we replaced each of them by turn with Ala.
Calculations gave negative values of ΔGapp for both Ala variants (D14A and D25A), indicating
that the peptides might adopt transbilayer helical conformations at neutral pH, and we observed
the presence of some elements of secondary structure for both peptides in presence of liposomes
(Figure 3). The observed helical content increases with a drop of pH, most probably due to
protonation of the single remaining Asp residue. It is interesting to note that the prediction
indicates that D25A has a higher probability to form a TM helix at neutral pH than the D14A
variant. Our fluorescence and CD data show that D25A is partly helical and, probably, more
aggregated in solution in the absence of lipids, since the position of the fluorescence maximum
is blue shifted (339 nm in contrast to 342 nm for D14A and 349 nm for WT-pHLIP) (Table 3).
Also, the addition of lipids at pH 8.0 leads to a further blue shift and enhancement of the
quantum yield, while a drop of pH does not lead to any other changes of the fluorescence signal
of the D25A variant. At the same time, we observed a progressive blue shift and increase in
fluorescence intensity for D14A as a result of the addition of lipids and a drop of pH. The
results indicate that both Asp's at position 14 and 25 are vital for maintaining the solubility of
the peptide and its insertion properties. These findings are in agreement with our results
indicating that 1.5-1.8 H+ are involved in the protonation reaction (18).
3D-Asp-pHLIP variant
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We thought that it would be desirable, if possible, to increase the cooperativity of insertion in
order to target a narrower pH range. For this purpose, we designed a peptide with an additional
Asp residue positioned between two inherent Asp residues, the “3D” peptide. The 3D peptide
was designed to have values of ΔGapp comparable to WT-pHLIP (Table 2). Replacement of
19Thr with Leu and insertion of another Leu at position 28 was required to make up for the
hydrophilicity of the added Asp and to ensure that the peptide would be hydrophobic enough
to insert into a membrane (Table 1). Disappointingly, the CD spectrum of the 3D peptide in
solution showed significant helical character even at a concentration of 3 μM (data not shown),
and the emission of tryptophan residues was blue shifted (344 nm), pointing to an aggregated
state of the peptide in solution even at low concentrations. No further increase in tryptophan
fluorescence intensity is observed for the 3D peptide in the presence of POPC vesicles at either
pH 8 or pH 4, although a blue shift from 344 nm to 336 nm is apparent with the addition of
POPC at pH 8 (Figure 3A and Table 3). CD spectra of the peptide in the presence of liposomes
indicate helix formation at pH 8, where WT pHLIP has no helical structure (Figure 3B).
We conclude that the peptide lost key pHLIP properties. While the difference in hydrophobicity
is not significant, a notable difference of the calculated parameters for the 3D and WT-pHLIP
is in values of the hydrophobic moment (0.64 for 3D vs 0.39 for WT), indicating that a 3D
peptide helix would have more amphipathic character than WT, and perhaps suggesting a
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design refinement. It may be that the 3D peptide does not insert into a lipid bilayer at neutral
pH, but adopts a surface helical configuration as many amphipathic peptides do.
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Glu-pHLIP variants
With the aim of differentially targeting tissue regions of various acidity, we explored the
possibility of tuning the pH at which pHLIP inserts across a membrane. We studied peptides
where one or the other of the TM Asp residues is replaced with Glu (D14E and D25E). We
expected that these changes would have only modest effects on hydrophbicity, and calculation
revealed little alteration in the parameters of ΔGaa(i)app, hydrophobic moment and peptide
length (Table 2). Thus, the apparent free energy differences for both Glu variants are close to
the WT-pHLIP, and fluorescence and CD spectra of each variant in the absence and presence
of lipids are similar to the WT-pHLIP. In the presence of lipids at pH 8, the tryptophan
fluorescence spectrum is shifted from 349 nm to 341-342 nm and its intensity increases, and
at pH 4 the spectrum is shifted further to 336 nm with an additional increase of fluorescence
intensity (Fig. 3A and Table 3). The peptides remain unstructured in the presence of liposomes
at pH 8 and become helical at pH 4, as observed from CD signals (Fig. 3B). These findings
are consistent with peptide binding to the lipid surface at pH 8 and TM formation across a lipid
bilayer at pH 4, like WT-pHLIP.
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Encouraged by the data obtained with the D14E and D25E variants, we studied the double
mutant with both Asp residues in the transmembrane domain replaced by Glu, the D14/25E
peptide. A negligible difference of calculated parameters was obtained for the D14/25E variant
in comparison with WT-pHLIP (Table 2). However, the peptide has very different behavior in
solution. The fluorescence spectrum of the D14/25E variant is 7 nm shifted to shorter
wavelengths (342 nm vs. 349 nm of WT-pHLIP) and the helical structure is observed at very
low peptide concentrations. Also noticeable is the enhanced quantum yield of the peptide in
solution (4 times higher than for WT-pHLIP and the D14E and D25E variants), which could
be from aggregation or altered peptide configuration such that Trp residues are shielded from
water molecules or other peptide groups that might quench tryptophan emission. No changes
are observed in tryptophan fluorescence when POPC vesicles are added at pH 8. Although a
small blue shift and increase in fluorescence intensity was observed at pH 4 in the presence of
liposomes, it is comparable to the fluorescence spectrum of the peptide in solution at pH 4,
when the peptide is aggregated (Figure 3A). The CD spectrum for the peptide shows a shift in
minima indicative of increased helicity when the pH is decreased from pH 8 to pH 4 (Figure
3B).
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Our results show that pHLIP configuration in solution is easily perturbed by seemingly small
sequence changes, which lead to the formation of some elements of helical structure and a loss
of pH-dependent membrane-insertion properties. Therefore, the design of new sequences
should be based not only on the calculation of the stability of TM helices, but also a more
challenging evaluation of the propensity to form helical structure in solution and to aggregate.
There is a known importance of the position of various amino acids in the alpha-helices of
globular proteins, for example it is known that Ala has the highest tendency to be found in the
middle of an alpha-helix, and, unexpectedly, that Glu has a much higher tendency than Asp to
form a helix in aqueous solution (25). This might explain why helix formation in solution was
found when the two Asp residues were simultaneously replaced with Glu residues.
Tuning pKa of insertion
Several pHLIP variants have been analyzed in this and other studies, and almost all of them
lack the key pHLIP property of pH-dependent membrane insertion (4,19). Only two variants,
the D14E and D25E peptides, remain soluble and monomeric in solution and insert across a
lipid bilayer in a pH-dependent fashion like WT-pHLIP. We evaluated the pKa values of
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insertion of each variant in comparison with WT-pHLIP. The position of the fluorescence
maximum of each peptide in the presence of POPC vesicles was measured as a function of pH.
The data were fitted using a nonlinear regression model, giving a pKa of 5.96±0.05 for the WTpHLIP (Table 4), which is consistent with the previous reports (14). Importantly, the titration
curves for the variants were found to be shifted to higher pH, indicating that each peptide
requires a less acidic environment for membrane insertion than WT-pHLIP (Fig. 4).
Conclusion
We have tested sequence variants of pHLIP to learn which features are variable within the
requirement that the pHLIP properties of solubility and pH-dependent insertion across a
membrane are preserved. We showed that the two TM Asp residues are each important, and
we found that most sequence variations compromise one or more of the key pHLIP properties.
It is clear that the design of new sequences should be based not only on the ability to form a
TM helix, but also on minimizing the propensity for aggregation and helix formation in aqueous
solution. Of the variant sequences studied, only single Glu substitutions of each of the two Asp
positions in the transmembrane helix preserved pHLIP properties, while resulting in an increase
of the pKa of insertion by half a pH unit. As a result, we have found two new pHLIP variants,
which might be used to selectively target tissues having different degrees of acidity. These
variants will now be tested for translocation of molecules across membranes and for targeting
of acidic tissues, including tumors, in vivo.
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Figure 1.

A schematic representation of the three principal states of WT-pHLIP. State I: pHLIP is
unstructured and soluble in water at neutral pH, State II: pHLIP is unstructured and associated
with the bilayer surface, State III: pHLIP is inserted across a lipid bilayer as an alpha-helix.
Tryptophan fluorescence and CD spectra of the WT-pHLIP in each state are shown. A plot
corresponding to each state is added to the graph of the previous state. The fluorescence and
CD spectra corresponding to each state, together with the sketch of the peptide in each state is
color coded as follows: State I-blue, State II-green, State III-red. See text for detailed
explanations. Membrane models were obtained from RasMol images of lipid bilayers (26).
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Figure 2.

Tryptophan fluorescence (A) and CD (B) spectra of pHLIP variants in solution at pH 4 and 8
in the absence and presence of POPC vesicles are presented. The concentration of pHLIP
variants and POPC vesicles are 7 μM and mM, respectively. Blue and pink lines represent
peptides in phosphate buffer at pH 8.0 and pH 4.0, respectively; green and red lines represent
peptides in the presence of POPC vesices at pH 8.0 and pH 4.0, respectively. The positions of
fluorescence spectra maxima, Lmax, are given in Table 3.
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Figure 3.

pH induced insertions of pHLIP and two D to E variants across a lipid bilayer are shown. The
titration was monitored by the shift of tryptophan fluorescence spectra maxima of pHLIP
peptides in the presence of POPC in response to a decrease of pH from 8.0 to 4.0. The values
of the position of fluorescence spectra maxima are the averages of at least three independent
measurements ± standard errors. The curves represent the best-fits of the experimental data
using the GraphPad Prism software. pKa insertion values of pHLIP variants calculated from
the plots are shown in Table 4.
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Sequences of pHILIP
pHLIP

variants.*

Sequnece

WT

AAEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT

D14A

AAEQNPIYWARYAAWLFTTPLLLLDLALLVDADEGT

D25A

AAEQNPIYWARYADWLFTTPLLLLALALLVDADEGT

D14E

AAEQNPIYWARYAEWLFTTPLLLLDLALLVDADEGT

D25E

AAEQNPIYWARYADWLFTTPLLLLELALLVDADEGT

D14/25E

AAEQNPIYWARYAEWLFTTPLLLLELALLVDADEGT

3D

AAEQNPIYWARYADWLFTDLPLLLLDLLALLVDADEGT

*

TM segment (based on the bacteriorhodopsin structure) is highlighted in blue and changed or inserted residues are marked in red.
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Table 2

NIH-PA Author Manuscript

The apparent free energy difference (ΔGapp) calculated for the potential TM helices of pHLIP variants.*
Δ Gaa(i)app†

Δ Ghyd.mom

Δ Glength

Δ Gapp

WT

+0.13

+0.39

0.00

+0.53

D14A

−0.59

+0.21

0.00

−0.38

D25A

−1.14

+0.21

0.00

−0.92

D14E

+0.28

+0.43

0.00

+0.71

D25E

0.00

+0.37

0.00

+0.37

D14/25E

+0.15

+0.40

0.00

+0.55

3D

+0.33

+0.64

−0.32

+0.66

*

Prediction of ΔG for TM helix insertion was based on the ΔG prediction server v1.0 found at http://www.cbr.su.se/DGpred/index.php?p=Tmpred.
A negative value of ΔGapp indicates that the sequence is predicted to be recognized as a TM helix by the Sec translocon and integrated into the
membrane, a positive value of ΔGapp does not necessarily mean that the peptide is not a transmembrane helix.
†

ΔGaa(i)app is the contribution from amino acid aa in position i.
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Table 3

NIH-PA Author Manuscript

Position of tryptophan fluorescence spectra maxima (Lmax) of pHLIP variants in the absence and presence of
POPC at pH 8 or pH 4.*
pHLIP

Buffer

POPC

pH 8

pH 4

pH 8

pH 4

WT

349 nm

336 nm

343 nm

336 nm

D14A

342 nm

335 nm

337 nm

336 nm

D25A

339 nm

337 nm

336 nm

336 nm

3D

344 nm

336 nm

337 nm

336 nm

D14/25E

342 nm

336 nm

339 nm

337 nm

D14E

349 nm

337 nm

341 nm

336 nm

D25E

349 nm

336 nm

342 nm

336 nm

*

Lmax values correspond to the numbers obtained from fluorescence curves in Figure 1 for the WT-pHLIP and Figure 3A for pHLIP variants.
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Table 4

NIH-PA Author Manuscript

Insertion pKa values of WT-pHLIP and its D to E variants across a membrane, calculated from the fitting of the
titration curves obtained by measurement of tryptophan fluorescence spectra of peptides in the presence of POPC
vesicles at different pHs.
pHLIP Variants

WT

D14E

D25E

pKa

5.96 ± 0.05

6.46 ± 0.08

6.49 ± 0.08
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